People news: Teva

Teva, the world's largest generic drug manufacturer, said president and CEO William S. Marth has resigned and will be replaced by Allan Oberman, who was previously SVP for North American generics. Oberman will oversee Teva's generics business in the Americas. Marth will stay on as senior adviser to global president and CEO Jeremy Levin until his retirement at the end of next year. Teva also brought on Jill DeSimone as SVP, general manager for Teva's global women's health franchise.
You must be a registered member of MMM to post a comment.

Did you miss January's Top 40 Healthcare Transformers issue? Read how these inventors, strategists, entrepreneurs and wonks are challenging, disrupting and otherwise transforming the healthcare business. And join us April 30 to honor them at the Transforming Healthcare Dinner. Click here.